Colorectal cancer screening with fecal occult blood testing

Abstract

Colorectal cancer (CRC) is a public health issue worldwide. Both in Europe and in most developed countries colorectal cancer represents the second most common neoplasm in both genders, and the second most common cause of cancer-related death. Most deaths from colorectal cancer may be prevented, and there is solid consensus on the need for CRC screening programs in the mid-risk population. The most efficient strategy remains to be defined, regarding which the development of an easily administered, highly sensitive, specific test bringing about an improvement of current adherence is essential. Increased awareness among the population regarding the benefits of early diagnosis, and straightforward access to healthcare resources are important issues.